06/04/2026
💊 BIG NEWS FOR MEDICARE BENEFICIARIES INTERESTED IN GLP-1 WEIGHT LOSS MEDICATIONS
Beginning July 1, 2026, Medicare will launch a temporary program called the Medicare GLP-1 Bridge, which may allow eligible Medicare beneficiaries to access certain GLP-1 weight loss medications for a $50 monthly copay. The program is currently scheduled to run through December 31, 2027.
A few important things to know:
✅ This program is administered directly by CMS (Medicare), not by your Medicare Part D or Medicare Advantage plan.
✅ Eligibility requirements apply and must be verified by your healthcare provider.
✅ Your provider must submit a prior authorization request on your behalf.
✅ The program is intended for qualifying weight management use and does not replace existing Medicare drug coverage for conditions such as diabetes, certain cardiovascular conditions, or sleep apnea.
✅ Because this program is separate from your Medicare drug plan, the $50 copay does NOT apply toward your Part D deductible or your annual Part D maximum out-of-pocket costs.
If you think you may qualify, your first step should be a conversation with your physician to discuss whether a GLP-1 medication is appropriate for you and whether you meet the program requirements.
For official information directly from CMS, visit:
https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge
As always, I'm happy to help explain how Medicare works, but eligibility and enrollment in this program will be determined by CMS and your healthcare provider.
